CS
LIXTW

Clear Street’s Lixte Biotechnology Warrants LIXTW Stock Holding History

Clear Street’s Portfolio LIXTW Stock Details LIXTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,618
Closed -$3.12K – 969
2025
Q3 		$3.12K Sell
21,618
-1,036
-5% -$206 ﹤0.01% 740
2025
Q2 		$648 Hold
22,654
– – ﹤0.01% 618
2025
Q1 		$766 Buy
22,654
+100
+0.4% +$3 ﹤0.01% 501
2024
Q4 		$650 Hold
22,554
– – ﹤0.01% 506
2024
Q3 		$922 Sell
22,554
-600
-3% -$29 ﹤0.01% 596
2024
Q2 		$1.38K Hold
23,154
– – ﹤0.01% 631
2024
Q1 		$1.16K Sell
23,154
-100
-0.4% -$7 ﹤0.01% 633
2023
Q4 		$872 Hold
23,254
– – ﹤0.01% 636
2023
Q3 		$1.69K Buy
23,254
+100
+0.4% +$7 ﹤0.01% 825
2023
Q2 		$2.08K Sell
23,154
-100
-0.4% -$7 ﹤0.01% 960
2023
Q1 		$2K Sell
23,254
-62,057
-73% -$7.06K ﹤0.01% 869
2022
Q4 		$5K Hold
85,311
– – ﹤0.01% 654
2022
Q3 		$4K Buy
85,311
+100
+0.1% +$13 ﹤0.01% 832
2022
Q2 		$10K Buy
+85,211
New +$17.2K ﹤0.01% 538

Clear Street's LIXTW Position: Q4 2025 in Review

Clear Street sold out of Lixte Biotechnology Warrants (LIXTW) in Q4 2025, closing a stake of 21,618 shares — an estimated $3.12K sold.

Clear Street first reported a position in LIXTW in Q2 2022 and held it in 14 quarters. The position peaked at $10K in Q2 2022. 0 funds tracked by Wall St. Rank hold LIXTW as of Q4 2025.

  • Clear Street reported no remaining Lixte Biotechnology Warrants position as of Q4 2025 after selling out during the quarter.
  • Clear Street sold 21,618 Lixte Biotechnology Warrants shares in Q4 2025, an estimated $3.12K.
  • Clear Street first reported a position in Lixte Biotechnology Warrants in Q2 2022 and held it in 14 quarters.
  • Clear Street's Lixte Biotechnology Warrants position peaked at $10K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Lixte Biotechnology Warrants as of Q4 2025.

Based on Clear Street's 13F filing for Q4 2025, filed 13 Feb 2026.